Related Experiment Video
Updated: May 25, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.3K
Interventions to improve medication adherence in persons with mental disorders
Jahnavi Kedare1, Abhijeet Faye2
1Department of Psychiatry, T. N. Medical College, B. Y. L. Nair Ch. Hospital, Mumbai.
Current Opinion in Psychiatry
|February 26, 2025
Summary
Medication nonadherence in mental illness leads to poor outcomes. Effective interventions, including technology-based approaches and collaborative care, are crucial for improving patient adherence and quality of life.
Area of Science:
- Psychiatry
- Behavioral Science
- Health Services Research
Background:
- Medication nonadherence is common in patients with mental illness.
- It results in increased hospitalizations, suicide risk, and healthcare costs.
- Effective interventions are needed to improve adherence.
Purpose of the Study:
- To review current interventions for improving medication adherence in patients with mental illness.
- To highlight the role of patient involvement and caregiver support.
- To explore the potential of technology-based interventions.
Main Methods:
- Review of recent interventions for medication adherence.
- Inclusion of psychoeducation, motivational interviewing, and cognitive behavioral therapy.
- Examination of technology-based approaches (smartphones, apps, AI).
Main Results:
- Interventions involving patients and caregivers show promise.
- Technology-based interventions are an emerging area of research.
- Combining different intervention methods may be most effective.
- Conventional methods also yield positive results.
Conclusions:
- Medication nonadherence negatively impacts health and social integration.
- Collaborative efforts among healthcare providers, patients, and caregivers are essential.
- Improving adherence leads to better health outcomes and quality of life.
More Related Videos
Related Concept Videos
01:28Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34
01:26Psychosis: Goals of Pharmacotherapy
102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
01:30Community Based Intervention
28
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
28
01:23Antidepressant Drugs: MAOIs and Other Agents
176
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
176
01:28Psychosis and Antipsychotic Drugs: Overview
171
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
171
01:24Mania and Antimanic Drugs: Overview
113
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
113